During the past decade, Novel Clinical Research Center, LLC. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Novel Clinical Research Center, LLC." are "Neuropsychiatric Symptoms Related to Neurodegenerative Disease" (2 trials), "Agitation" (1 trials), "Alzheimer's Type Dementia" (1 trials), "Dementia-related Psychosis" (1 trials) and "Migraine" (1 trials). Many other conditions were trialed in "Novel Clinical Research Center, LLC." in a lesser frequency.

Most popular intervention types in "Novel Clinical Research Center, LLC." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Pimavanserin" (2 trials), "Dihydroergotamine" (1 trials), "Droxidopa capsules" (1 trials) and "Masupirdine 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Novel Clinical Research Center, LLC." are 6 trials for "All" genders.

Currently, there are NaN active trials in "Novel Clinical Research Center, LLC.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Novel Clinical Research Center, LLC., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Novel Clinical Research Center, LLC., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".